-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓USDISIN US88338N1072-
THERAPEUTICSMD INCBörse Börse MünchenEURSymbol 29T
-
THERAPEUTICSMD INCBörse Börse StuttgartEURSymbol 29T
-
THERAPEUTICSMD INCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol 29T
-
THERAPEUTICSMD INCBörse Gettex System der Börse MünchenEURSymbol 29T
-
ISIN US88338N1072 WKN: A1W1WNUSDSymbol TXMD
-
EURSymbol 29T
-
EURSymbol 29T
-
ISIN US88338N1072
WKN A1W1WN
Symbol TXMD
Währung
USD
Firmenname
TherapeuticsMD, Inc
Marktkapitalisierung
535.089.536 (+- 17%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
627.179.072 oder 443.000.000
Mitarbeiter
374 (+- 7%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
348 oder 400 Mitarbeiter
EBITDA -151.833.168
PEGRatio -0.73
Buchwert 0.034
TherapeuticsMD Inc outperformed den DAX um +38 % vom 08.05.2014 bis 12.04.2017
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 1,4 USD -2,67%
5 ETFs die in TherapeuticsMD Inc investieren
Dir gefallen die Informationen zu TherapeuticsMD Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu TherapeuticsMD Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu TherapeuticsMD Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu TherapeuticsMD Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
21 News & Informationen zur TherapeuticsMD Inc Aktie
Strongbridge Biopharma : Certain Litigation Relating to the Transaction (Form 8-K)
Certain Litigation Relating to the Transaction
As previously disclosed, on May 24, 2021, Strongbridge Biopharma plc entered into a Transaction Agreement with Xeris… | August 30, 2021
TherapeuticsMD Announces Issuance Of A J-Code For ANNOVERA® To Be Utilized In The Public Health Sector
TherapeuticsMD, Inc. TXMD, an innovative, leading women's healthcare company, today announced that the Centers for Medicare and Medicaid Services (CMS)
22 Stocks Moving in Friday's Pre-Market Session
Gainers GeoVax Labs, Inc.. (NASDAQ:GOVX) shares rose 72.1% to $7.40 in pre-market trading after the company announced it presented COVID-19 vacc…
Pre-market Movers: GOVX, PROG, SONN, MRIN, NVIV…
The following are some of the stocks making big moves in Friday's pre-market trading (as of 5.40 A.M. EDT)..
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc. (NYSE: BIO) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) Gilead Sciences, Inc. (NASDAQ: GILD) GlaxoSmithKline plc (NYSE: GSK) Johnson & Johnson (NYSE: JNJ) Laboratory Corporation of America Holdings (NYSE: LH) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) NanoVibronix, Inc. (NASDAQ: NAOV) (announced intention to enter over-
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Au…
Sesen Bio Strengthens Executive Leadership Team As The Company Approaches The Potential Approval And Commercial Launch Of Vicineum™
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today
TherapeuticsMD : Announces Appointment of Hugh O'Dowd as President
– O’Dowd brings 25+ years of experience in senior leadership roles with leading pharmaceutical companies –
… | August 9, 2021
TherapeuticsMD Announces Appointment Of Hugh O'Dowd As President
TherapeuticsMD, Inc. TXMD, an innovative, leading women's healthcare company, today announced the appointment of Hugh O'Dowd as President. Mr. O'Dowd succeeds
TherapeuticsMD, Inc. 2021 Q2 – Results – Earnings Call Presentation (NASDAQ:TXMD)
The following slide deck was published by TherapeuticsMD, Inc.
Were Hedge Funds Right About MBIA Inc. (MBI)?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900…
28 Stocks Moving in Friday's Pre-Market Session
Gainers Toughbuilt Industries Inc (NASDAQ:TBLT) shares rose 61% to $1.16 in pre-market trading after the company reported 1H sales through Amazo…
Pharmaceutical Executive® APEX Awards Announces 2021 Finalists
/PRNewswire/ — Pharmaceutical Executive®, a leading multimedia platform for industry leaders to exchange experiences and insights about innovative business…
Pharmaceutical Executive® APEX Awards Announces 2021 Finalists
CRANBURY, N.J., July 8, 2021 /PRNewswire/ — Pharmaceutical Executive®, a leading multimedia platform for industry leaders to exchange experiences and
10 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman
In this article, we will discuss the 10 best pharmaceutical stocks to buy according to billionaire Joseph Edelman. If you want to skip our detailed analysis…
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors
Shares of TherapeuticsMD Inc. shed 4.17% to $1.38 Friday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ…
TherapeuticsMD Inc. stock rises Thursday, outperforms market
Shares of TherapeuticsMD Inc. advanced 1.41% to $1.44 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the…
TherapeuticsMD Inc. stock outperforms market on strong trading day
Shares of TherapeuticsMD Inc. rallied 3.65% to $1.42 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the…
TherapeuticsMD (TXMD) Surges: Stock Moves 6.8% Higher
TherapeuticsMD (TXMD) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
TherapeuticsMD Inc. stock rises Monday, outperforms market
Shares of TherapeuticsMD Inc. rallied 6.77% to $1.42 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ…
TherapeuticsMD Inc. stock outperforms competitors despite losses on the day
Shares of TherapeuticsMD Inc. shed 2.27% to $1.29 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow…